Age, period and cohort effects on time trends in monthly cannabis use in adult population: 1996-2019.


Journal

Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440

Informations de publication

Date de publication:
07 2023
Historique:
revised: 22 02 2023
received: 30 08 2022
accepted: 20 03 2023
medline: 7 7 2023
pubmed: 7 4 2023
entrez: 6 4 2023
Statut: ppublish

Résumé

With changes in norms related to cannabis use and in the regulation of cannabis, understanding trends in cannabis use is important, especially differentiating between trends that affect cohorts of all ages similarly, versus trends that disproportionately affect a younger generation. The present study examined the age-period-cohort (APC) effects on monthly cannabis use among adults in Ontario, Canada over a 24-year period. Data were utilised from the Centre for Addiction and Mental Health Monitor Survey, an annual repeated cross-sectional survey of adults 18 years of age and older. The present analyses focused on the 1996 to 2019 surveys, which employed a regionally stratified sampling design using computer-assisted telephone interviews (N = 60,171). Monthly use of cannabis stratified by sex were examined. There was about a five-fold increase in monthly cannabis use from 1996 (3.1%) to 2019 (16.6%). The youngest adults use cannabis monthly more, but the patterns of monthly cannabis use appeared to be increasing among older adults. Adults born in the 1950s had higher prevalence of cannabis use (1.25 times more likely to use) compared to those born in 1964, with strongest period effect in 2019. The subgroup analysis of monthly cannabis use by sex showed little variation in APC effects. There is a change in patterns of cannabis use among older adults and inclusion of birth cohort dimension improves the explanation of cannabis use trends. Adults in the 1950s birth cohort and increases in the normalisation of cannabis use could also be the key to explaining increasing monthly cannabis use.

Identifiants

pubmed: 37022009
doi: 10.1111/dar.13658
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1132-1141

Subventions

Organisme : CIHR
ID : 170394
Pays : Canada
Organisme : CIHR
ID : SMN-13950
Pays : Canada

Informations de copyright

© 2023 Australasian Professional Society on Alcohol and other Drugs.

Références

Cerda M, Mauro C, Hamilton A, Levy NS, Santaella-Tenorio J, Hasin D, et al. Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016. JAMA Psychiatry. 2020;77:165-71.
Moss SL, Santaella-Tenorio J, Mauro PM, Keyes KM, Martins SS. Changes over time in marijuana use, deviant behavior and preference for risky behavior among US adolescents from 2002 to 2014: testing the moderating effect of gender and age. Addiction. 2019;114:674-86.
Anciaux A. Cannabis, brain impact, and legalization in the United States. Arch Med Res. 2019;50:269-70.
Lowe DJE, Sasiadek JD, Coles AS, George TP. Cannabis and mental illness: a review. Eur Arch Psychiatry Clin Neurosci. 2019;269:107-20.
Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219-27.
Campeny E, López-Pelayo H, Nutt D, Blithikioti C, Oliveras C, Nuño L, et al. The blind men and the elephant: systematic review of systematic reviews of cannabis use related health harms. Eur Neuropsychopharmacol. 2020;33:1-35.
Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110:19-35.
National Academies of Sciences E and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research [Internet]. Washington, DC: The National Academies Press; 2017. Available from: https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state
Hall W, Weier M. Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clin Pharmacol Ther. 2015;97:607-15.
Hall W, Lynskey M. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction. 2016;111:1764-73.
Cox C. The Canadian cannabis act legalizes and regulates recreational cannabis use in 2018. Health Policy. 2018;122:205-9.
Health Canada. Canadian Tobacco, Alcohol and Drugs (CTADS) Survey: 2017 detailed tables [Internet]. 2018 [cited 14 August 2020]. Available from: https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2017-summary/2017-detailed-tables.html#t16
Statistics Canada. What has changed since cannabis was legalized? [Internet]. 2020 Feb p. 11-20. Report No.: 31. Available from: https://www150.statcan.gc.ca/n1/pub/82-003-x/2020002/article/00002-eng.htm
Coughenour P, Sadicario JS, Karjane N, Parlier-Ahmad AB, Phipps L, Svikis DS. Prevalence and social acceptability of cannabis, tobacco, and alcohol use in adult women. Womens Health Rep (New Rochelle). 2021;2:452-8.
Rotermann M. Analysis of trends in the prevalence of cannabis use and related metrics in Canada. Health Rep. 2019;30:3-13.
Rotermann M, Macdonald R. Analysis of trends in the prevalence of cannabis use in Canada, 1985 to 2015. Health Rep. 2018;29:10-20.
Zvonarev V, Fatuki TA, Tregubenko P. The public health concerns of marijuana legalization: an overview of current trends. Cureus. 2019;11:e5806.
Lowry DE, Corsi DJ. Trends and correlates of cannabis use in Canada: a repeated cross-sectional analysis of national surveys from 2004 to 2017. CMAJ Open. 2020;8:E487-95.
Chawla D, Yang YC, Desrosiers TA, Westreich DJ, Olshan AF, Daniels JL. Past-month cannabis use among U.S. individuals from 2002-2015: an age-period-cohort analysis. Drug Alcohol Depend. 2018;193:177-82.
Hopfer C. Implications of marijuana legalization for adolescent substance use. Subst Abus. 2014;35:331-5.
Ryder NB. The cohort as a concept in the study of social change. Am Sociol Rev. 1965;30:843-61.
Keyes KM, Utz RL, Robinson W, Li G. What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971-2006. Soc Sci Med. 2010;70:1100-8.
Kerr WC, Greenfield TK, Bond J, Ye Y, Rehm J. Age-period-cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug Alcohol Depend. 2007;86(2-3):132-8.
Kerr WC, Lui C, Ye Y. Trends and age, period and cohort effects for marijuana use prevalence in the. Addiction. 2018;113:473-81.
Kaur N, Keyes KM, Hamilton AD, Chapman C, Livingston M, Slade T, et al. Trends in cannabis use and attitudes toward legalization and use among Australians from 2001-2016: an age-period-cohort analysis. Addiction. 2021;116:1152-61.
Manthey J, Freeman TP, Kilian C, López-Pelayo H, Rehm J. Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates. Lancet Reg Health Eur. 2021;10:100227.
Newman JC, Des Jarlais DC, Turner CF, Gribble J, Cooley P, Paone D. The differential effects of face-to-face and computer interview modes. Am J Public Health. 2002;92:294-7.
Nigatu YT, Elton-Marshall T, Adlaf EM, Ialomiteanu A, Mann RE, Hamilton HA. CAMH Monitor e-Report: Substance Use, Mental Health and Well-Being Among Ontario Adults, 1977-2019. Toronto, ON: Centre for Addiction and Mental Health; 2020. Available from: http://www.camh.ca/camh-monitor
Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med. 2007;26:3018-45.
Rutherford MJ, Lambert PC, Thompson JR. Age-period-cohort modeling. Stata J. 2010;10:606-27.
Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551-61.
O'Brien RM. Model misspecification when eliminating a factor in age-period-cohort multiple classification models. Sociol Methodol. 2016;46:358-72.
Statistics Canada. Censuses of population, 1956 to 2006 [Internet]. Ottawa, Canada: Statistics Canada; 2009 [cited 16 February 2023]. Available from: https://www12.statcan.gc.ca/census-recensement/2006/as-sa/97-551/figures/c3-eng.cfm
Milligan I. Rebel youth: 1960s labour unrest, young workers, and new leftists in English Canada. Vancouver: University of British Columbia; 2014.
Baumbusch J, Sloan YI. Exploring new use of cannabis among older adults. Clin Gerontol. 2021;44:25-31.
Imtiaz S, Nigatu YT, Ali F, Douglas L, Hamilton HA, Rehm J, et al. Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001-2019). Drug Alcohol Depend. 2023;244:109765.
Public Safety Canada. Cannabis black market [Internet]. Ottawa: Public Safety Canada; 2020 [cited 16 February 2023]. Available from: https://www.publicsafety.gc.ca/cnt/trnsprnc/brfng-mtrls/prlmntry-bndrs/20200930/026/index-en.aspx
Haug NA, Padula CB, Sottile JE, Vandrey R, Heinz AJ, Bonn-Miller MO. Cannabis use patterns and motives: a comparison of younger, middle-aged, and older medical cannabis dispensary patients. Addict Behav. 2017;72:14-20.
Tumati S, Lanctôt KL, Wang R, Li A, Davis A, Herrmann N. Medical cannabis use among older adults in Canada: self-reported data on types and amount used, and perceived effects. Drugs Aging. 2022;39:153-63.
Miech R, Koester S. Trends in U.S., past-year marijuana use from 1985 to 2009: an age-period-cohort analysis. Drug Alcohol Depend. 2012;124:259-67.
Chapman C, Slade T, Swift W, Keyes K, Tonks Z, Teesson M. Evidence for sex convergence in prevalence of cannabis use: a systematic review and meta-regression. J Stud Alcohol Drugs. 2017;78:344-52.

Auteurs

Yeshambel T Nigatu (YT)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.

Tara Elton-Marshall (T)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Canada.

Sergio Rueda (S)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Institute of Medical Science, University of Toronto, Toronto, Canada.
Department of Psychiatry, University of Toronto, Toronto, Canada.

Sameer Imtiaz (S)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.

Hayley A Hamilton (HA)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH